171 related articles for article (PubMed ID: 18381475)
1. Prediagnostic use of hormone therapy and mortality after breast cancer.
Newcomb PA; Egan KM; Trentham-Dietz A; Titus-Ernstoff L; Baron JA; Hampton JM; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):864-71. PubMed ID: 18381475
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement therapy and breast cancer survival in a large screening study.
Schairer C; Gail M; Byrne C; Rosenberg PS; Sturgeon SR; Brinton LA; Hoover RN
J Natl Cancer Inst; 1999 Feb; 91(3):264-70. PubMed ID: 10037105
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy in relation to survival from large bowel cancer.
Newcomb PA; Chia VM; Hampton JM; Doria-Rose VP; Trentham Dietz A
Cancer Causes Control; 2009 May; 20(4):409-16. PubMed ID: 18998219
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer and hormone-replacement therapy in the Million Women Study.
Beral V;
Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.
Kjartansdottir OJ; Sigurdardottir LG; Olafsdottir EJ; Jonasson JG; Ursin G; Tryggvadottir L
Breast Cancer Res Treat; 2017 Jun; 163(2):363-373. PubMed ID: 28281022
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and the risk of death from breast cancer: a systematic review.
Nanda K; Bastian LA; Schulz K
Am J Obstet Gynecol; 2002 Feb; 186(2):325-34. PubMed ID: 11854659
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
10. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.
Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P
Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850
[TBL] [Abstract][Full Text] [Related]
16. Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.
Obi N; Heinz J; Seibold P; Vrieling A; Rudolph A; Chang-Claude J; Berger J; Flesch-Janys D
Int J Cancer; 2016 May; 138(9):2098-108. PubMed ID: 26649645
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.
Yuen J; Persson I; Bergkvist L; Hoover R; Schairer C; Adami HO
Cancer Causes Control; 1993 Jul; 4(4):369-74. PubMed ID: 8394149
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
19. Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort.
Marshall SF; Clarke CA; Deapen D; Henderson K; Largent J; Neuhausen SL; Reynolds P; Ursin G; Horn-Ross PL; Stram DO; Templeman C; Bernstein L
Breast Cancer Res; 2010; 12(1):R4. PubMed ID: 20064209
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and mortality.
Grodstein F; Stampfer MJ; Colditz GA; Willett WC; Manson JE; Joffe M; Rosner B; Fuchs C; Hankinson SE; Hunter DJ; Hennekens CH; Speizer FE
N Engl J Med; 1997 Jun; 336(25):1769-75. PubMed ID: 9187066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
